Effect of different adjuvant formulations on the antibody response of horses to porcine zona pellucida proteins

• Published in: Veterinary immunology and immunopathology 2022-11, Vol.253, p.110507-110507, Article 110507
• Main Authors: AbdelKhalek, Ahmed, Ostafe, Raluca, Olave, Carla, HogenEsch, Harm, Turner, John W.
• Format: Article
• Language: English
• Subjects: Adjuvants; Horses; Immunocontraception; Nanoparticles; Vaccines; Zona Pellucida
• ISSN: 0165-2427; 1873-2534
• DOI: 10.1016/j.vetimm.2022.110507

Immunization with porcine zona pellucida (PZP) proteins is being used successfully to induce infertility in wildlife including horses. However, widespread adoption of this method to control the growth of horse populations requires further refinement in order to induce long-term infertility, reduce the frequency and severity of injection site reactions, and make the vaccines easier to administer. The next generation of PZP-based vaccines will likely be a controlled-release formulation with different adjuvants from the Freund’s adjuvants used in existing vaccines. We evaluated the response of equine peripheral blood mononuclear cells to a cationic nanoparticle adjuvant, Nano-11, alone and with the TLR agonists poly(I:C) and CpG ODN as a screen to develop an adjuvant system suitable for immunization of horses. The secretion of IL-1β, TNF and CXCL10 were used as readouts. The combination of poly(I:C) with Nano-11 significantly increased the secretion of IL-1β and TNF in comparison with Nano-11 only, with little effect of further addition of CpG ODN. The efficacy of the Nano-11/poly(I:C) adjuvant to enhance the immune response to native PZP proteins was determined in horses. Horses were immunized twice with the licensed Zonastat-H vaccine or PZP with Nano-11/poly(I:C) emulsified in silicone oil. A third group received PZP with the saponin adjuvant QA-21 emulsified in silicone oil. The horse sera collected monthly after the injections had increased anti-PZP IgG antibodies with the strongest response observed with Zonastat-H. We conclude that Nano-11/poly(I:C) is a potential candidate for the development of a controlled release formulation of a next generation PZP-based immunocontraception. •There is a need for improved PZP vaccine formulations for horses.•A nanoparticle/poly(I:C) adjuvant effectively induced cytokines in equine PBMCs.•Different vaccine formulations were evaluated for induction of anti-PZP antibodies.•Zonastat-H® and PZP with Nano-11/poly(I:C) induced the strongest antibody responses.•Antibodies from horses immunized with native PZP reacted with recombinant PZP3.